急诊科生理应激标志物与90天内再入院和死亡的关联:一项前瞻性观察研究

IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Lee Ti Davidson, Ulf Martin Schilling, Hans J Arnqvist, Fredrik H Nystrom, Simona I Chisalita
{"title":"急诊科生理应激标志物与90天内再入院和死亡的关联:一项前瞻性观察研究","authors":"Lee Ti Davidson,&nbsp;Ulf Martin Schilling,&nbsp;Hans J Arnqvist,&nbsp;Fredrik H Nystrom,&nbsp;Simona I Chisalita","doi":"10.48101/ujms.v128.9300","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Predicting the risk of readmission or death in patients at the emergency department (ED) is essential in identifying patients who would benefit the most from interventions. We aimed to explore the prognostic value of mid-regional proadrenomedullin (MR-proADM), mid-regional pro-atrial natriuretic peptide (MR-proANP), copeptin, and high-sensitivity troponin T (hs-TnT) to identify patients with a higher risk of readmission and death among patients presenting with chest pain (CP) and/or shortness of breath (SOB) in the ED.</p><p><strong>Methods: </strong>This single-center prospective observational study included non-critically ill adult patients with a chief complaint of CP and/or SOB who visited the ED at Linköping University Hospital. Baseline data and blood samples were collected, and patients were followed up for 90 days after inclusion. The primary outcome was a composite of readmission and/or death from non-traumatic causes within 90 days of inclusion. Binary logistic regression was used and receiver operating characteristics (ROC) curves were constructed to determine the prognostic performance for predicting readmission and/or death within 90 days.</p><p><strong>Results: </strong>A total of 313 patients were included and 64 (20.4%) met the primary endpoint. MR-proADM > 0.75 pmol/L (odds ratio [OR]: 2.361 [95% confidence interval [CI]: 1.031 - 5.407], <i>P</i> = 0.042) and multimorbidity (OR: 2.647 [95% CI: 1.282 - 5.469], <i>P</i> = 0.009) were significantly associated with readmission and/or death within 90 days. MR-proADM increased predictive value in the ROC analysis to age, sex, and multimorbidity (<i>P</i> = 0.006).</p><p><strong>Conclusions: </strong>In non-critically ill patients with CP and/or SOB in the ED, MR-proADM and multimorbidity may be helpful for the prediction of the risk of readmission and/or death within 90 days.</p>","PeriodicalId":23458,"journal":{"name":"Upsala journal of medical sciences","volume":"128 ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202081/pdf/","citationCount":"0","resultStr":"{\"title\":\"Association of physiological stress markers at the emergency department to readmission and death within 90 days: a prospective observational study.\",\"authors\":\"Lee Ti Davidson,&nbsp;Ulf Martin Schilling,&nbsp;Hans J Arnqvist,&nbsp;Fredrik H Nystrom,&nbsp;Simona I Chisalita\",\"doi\":\"10.48101/ujms.v128.9300\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Predicting the risk of readmission or death in patients at the emergency department (ED) is essential in identifying patients who would benefit the most from interventions. We aimed to explore the prognostic value of mid-regional proadrenomedullin (MR-proADM), mid-regional pro-atrial natriuretic peptide (MR-proANP), copeptin, and high-sensitivity troponin T (hs-TnT) to identify patients with a higher risk of readmission and death among patients presenting with chest pain (CP) and/or shortness of breath (SOB) in the ED.</p><p><strong>Methods: </strong>This single-center prospective observational study included non-critically ill adult patients with a chief complaint of CP and/or SOB who visited the ED at Linköping University Hospital. Baseline data and blood samples were collected, and patients were followed up for 90 days after inclusion. The primary outcome was a composite of readmission and/or death from non-traumatic causes within 90 days of inclusion. Binary logistic regression was used and receiver operating characteristics (ROC) curves were constructed to determine the prognostic performance for predicting readmission and/or death within 90 days.</p><p><strong>Results: </strong>A total of 313 patients were included and 64 (20.4%) met the primary endpoint. MR-proADM > 0.75 pmol/L (odds ratio [OR]: 2.361 [95% confidence interval [CI]: 1.031 - 5.407], <i>P</i> = 0.042) and multimorbidity (OR: 2.647 [95% CI: 1.282 - 5.469], <i>P</i> = 0.009) were significantly associated with readmission and/or death within 90 days. MR-proADM increased predictive value in the ROC analysis to age, sex, and multimorbidity (<i>P</i> = 0.006).</p><p><strong>Conclusions: </strong>In non-critically ill patients with CP and/or SOB in the ED, MR-proADM and multimorbidity may be helpful for the prediction of the risk of readmission and/or death within 90 days.</p>\",\"PeriodicalId\":23458,\"journal\":{\"name\":\"Upsala journal of medical sciences\",\"volume\":\"128 \",\"pages\":\"\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202081/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Upsala journal of medical sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.48101/ujms.v128.9300\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Upsala journal of medical sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.48101/ujms.v128.9300","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:预测急诊科(ED)患者再入院或死亡的风险对于确定从干预措施中获益最多的患者至关重要。我们的目的是探讨中区肾上腺髓质素原(MR-proADM)、中区心房利钠肽原(MR-proANP)、copeptin和高敏感性肌钙蛋白T (hs-TnT)的预后价值,以识别在ed中出现胸痛(CP)和/或呼吸短促(SOB)的患者中再住院和死亡风险较高的患者。这项单中心前瞻性观察研究纳入了到Linköping大学医院急诊科就诊的主诉为CP和/或SOB的非危重成年患者。收集基线资料和血液样本,纳入后随访患者90天。主要结局是入院后90天内再入院和/或非创伤性死亡的综合结果。采用二元逻辑回归并构建受试者工作特征(ROC)曲线,以确定预测90天内再入院和/或死亡的预后表现。结果:共纳入313例患者,64例(20.4%)达到主要终点。MR-proADM > 0.75 pmol/L(比值比[OR]: 2.361[95%可信区间[CI]: 1.031 ~ 5.407], P = 0.042)和多发病(比值比[OR]: 2.647 [95% CI: 1.282 ~ 5.469], P = 0.009)与90天内再入院和/或死亡显著相关。MR-proADM在ROC分析中增加了对年龄、性别和多病性的预测价值(P = 0.006)。结论:在急诊科合并CP和/或SOB的非危重患者中,MR-proADM和多病性可能有助于预测90天内再入院和/或死亡的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Association of physiological stress markers at the emergency department to readmission and death within 90 days: a prospective observational study.

Association of physiological stress markers at the emergency department to readmission and death within 90 days: a prospective observational study.

Background: Predicting the risk of readmission or death in patients at the emergency department (ED) is essential in identifying patients who would benefit the most from interventions. We aimed to explore the prognostic value of mid-regional proadrenomedullin (MR-proADM), mid-regional pro-atrial natriuretic peptide (MR-proANP), copeptin, and high-sensitivity troponin T (hs-TnT) to identify patients with a higher risk of readmission and death among patients presenting with chest pain (CP) and/or shortness of breath (SOB) in the ED.

Methods: This single-center prospective observational study included non-critically ill adult patients with a chief complaint of CP and/or SOB who visited the ED at Linköping University Hospital. Baseline data and blood samples were collected, and patients were followed up for 90 days after inclusion. The primary outcome was a composite of readmission and/or death from non-traumatic causes within 90 days of inclusion. Binary logistic regression was used and receiver operating characteristics (ROC) curves were constructed to determine the prognostic performance for predicting readmission and/or death within 90 days.

Results: A total of 313 patients were included and 64 (20.4%) met the primary endpoint. MR-proADM > 0.75 pmol/L (odds ratio [OR]: 2.361 [95% confidence interval [CI]: 1.031 - 5.407], P = 0.042) and multimorbidity (OR: 2.647 [95% CI: 1.282 - 5.469], P = 0.009) were significantly associated with readmission and/or death within 90 days. MR-proADM increased predictive value in the ROC analysis to age, sex, and multimorbidity (P = 0.006).

Conclusions: In non-critically ill patients with CP and/or SOB in the ED, MR-proADM and multimorbidity may be helpful for the prediction of the risk of readmission and/or death within 90 days.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Upsala journal of medical sciences
Upsala journal of medical sciences 医学-医学:内科
CiteScore
5.60
自引率
0.00%
发文量
31
审稿时长
6-12 weeks
期刊介绍: Upsala Journal of Medical Sciences is published for the Upsala Medical Society. It has been published since 1865 and is one of the oldest medical journals in Sweden. The journal publishes clinical and experimental original works in the medical field. Although focusing on regional issues, the journal always welcomes contributions from outside Sweden. Specially extended issues are published occasionally, dealing with special topics, congress proceedings and academic dissertations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信